301087 可孚医疗
2026/06 - 中期
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入2,071,84838.51%3,387,4992,982,9312,853,6952,976,958
减:营业总成本1,846,03939.39%3,038,8062,630,6582,594,3862,646,291
    其中:营业成本913,93628.61%1,586,6081,436,0841,618,6611,800,683
               财务费用11,068-456.84%(2,987)(22,828)(19,062)(33,291)
               资产减值损失(16,879)-45.43%(31,813)(33,803)(52,180)(46,304)
公允价值变动收益19,84680.74%49,8429,400(1,563)4,402
投资收益(5,185)-136.02%15,84512,34247,71556,750
    其中:对联营企业和合营企业的投资收益(6,228)-1,068.42%779(3,498)(130)(21)
营业利润244,41424.02%429,044373,304294,728368,407
利润总额244,07022.24%425,843371,999285,708334,388
减:所得税费用40,87123.79%55,52759,65632,83732,369
净利润203,19921.94%370,316312,344252,871302,020
减:非控股权益935-225.61%(1,292)593(1,409)336
股东净利润202,26420.84%371,609311,751254,280301,683

市场价值指针
每股收益 (元) *0.95015.85%1.8301.5301.2401.450
每股派息 (元) *----1.8001.8001.2001.200
每股净资产 (元) *----23.29822.94023.41424.080
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容